CLINICAL RESEARCH: POST-INFARCTION RISK
Noninvasive Risk Assessment Early After a Myocardial InfarctionThe REFINE Study
Derek V. Exner, MD, MPH*, ,1,*,
Katherine M. Kavanagh, MD*, ,
Michael P. Slawnych, MD, PhD*,
L. Brent Mitchell, MD*,
Darlene Ramadan, BSN*,
Sandeep G. Aggarwal, MD*,
Catherine Noullett, RN*,
Allie Van Schaik, RN ,
Ryan T. Mitchell, BSc*,
Mariko A. Shibata, BSc*,
Sajad Gulamhussein, MD ,
James McMeekin, MD*,
Wayne Tymchak, MD ,
Gregory Schnell, MD*,
Anne M. Gillis, MD*,2,
Robert S. Sheldon, MD, PhD*,
Gordon H. Fick, PhD ,
Henry J. Duff, MD*,2 for the REFINE Investigators
* Libin Cardiovascular Institute of Alberta, Calgary, Canada
Department of Community Health Sciences, University of Calgary, Calgary, Canada
Department of Medicine, University of Alberta, Edmonton, Canada.
Manuscript received May 23, 2007;
revised manuscript received August 3, 2007,
accepted August 13, 2007.
* Reprint requests and correspondence: Dr. Derek V. Exner, 3330 Hospital Drive NW, Room G208, Calgary, Alberta, Canada T2N 4N1. (Email: exner{at}ucalgary.ca).
Objectives: This study sought to determine whether combined assessment of autonomic tone plus cardiac electrical substrate identifies most patients at risk of serious events after myocardial infarction (MI) and to compare assessment at 2 to 4 weeks versus 10 to 14 weeks after MI.
Background: Methods to identify most patients at risk of serious events after MI are required.
Methods: Patients (n = 322) with an ejection fraction (EF) <0.50 in the initial week after MI were followed up for a median of 47 months. Serial assessment of autonomic tone, including heart rate turbulence (HRT), electrical substrate, including T-wave alternans (TWA), and EF was performed, interpreted blinded, and categorized using pre-specified cut-points where available. The primary outcome was cardiac death or resuscitated cardiac arrest. All-cause mortality and fatal or nonfatal cardiac arrest were secondary outcomes.
Results: Mean EF significantly increased over the initial 8 weeks after MI. Testing 2 to 4 weeks after MI did not reliably identify patients at risk, whereas testing at 10 to 14 weeks did. The 20% of patients with impaired HRT, abnormal exercise TWA, and an EF <0.50 beyond 8 weeks post-MI had a 5.2 (95% confidence interval [CI] 2.4 to 11.3, p < 0.001) higher adjusted risk of the primary outcome. This combination identified 52% of those at risk, with good positive (23%; 95% CI 17% to 26%) and negative (95%; 95% CI 93% to 97%) accuracy. Similar results were observed for the secondary outcomes.
Conclusions: Impaired HRT, abnormal TWA, and an EF <0.50 beyond 8 weeks after MI reliably identify patients at risk of serious events. (Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhythmias After a Heart Attack; http://www.clinicaltrials.gov/ct/show/NCT00399503?order=1; NCT00399503
[ClinicalTrials.gov]
)
|
Abbreviations and Acronyms
| | AUC = area under the receiver-operator characteristic curve | | BRS = baroreflex sensitivity | | CI = confidence interval | | ECG = electrocardiograph/electrocardiographic | | HRT = heart rate turbulence | | HRV = heart rate variability | | ICD = implantable cardioverter-defibrillator | | LV = left ventricular | | LVEF = left ventricular ejection fraction | | MI = myocardial infarction | | TWA = T-wave alternans | | VPB = ventricular premature beats |
|
Related Article
-
New Methods for Risk Stratification in Patients After Myocardial Infarction: Autonomic Control and Substrate Sensitivity
- Peter Sleight
J. Am. Coll. Cardiol. 2007 50: 2291-2293.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. J. Goldberger and R. Passman
Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial Infarction The Results Are Not Shocking.
J. Am. Coll. Cardiol.,
November 24, 2009;
54(22):
2001 - 2005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Takasugi, K. Nishigaki, T. Kubota, K. Tsuchiya, K. Natsuyama, M. Takasugi, T. Nawa, S. Ojio, T. Aoyama, M. Kawasaki, et al.
Sleep apnoea induces cardiac electrical instability assessed by T-wave alternans in patients with congestive heart failure
Eur J Heart Fail,
November 1, 2009;
11(11):
1063 - 1070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zaman, G. Sivagangabalan, A. Narayan, A. Thiagalingam, D. L. Ross, and P. Kovoor
Outcomes of Early Risk Stratification and Targeted Implantable Cardioverter-Defibrillator Implantation After ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
Circulation,
July 21, 2009;
120(3):
194 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bauer, J. Mehilli, P. Barthel, A. Muller, A. Kastrati, K. Ulm, A. Schomig, M. Malik, and G. Schmidt
Impact of Myocardial Salvage Assessed by 99mTc-Sestamibi Scintigraphy on Cardiac Autonomic Function in Patients Undergoing Mechanical Reperfusion Therapy for Acute Myocardial Infarction
J. Am. Coll. Cardiol. Img.,
April 1, 2009;
2(4):
449 - 457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Slawnych, T. Nieminen, M. Kahonen, K. M. Kavanagh, T. Lehtimaki, D. Ramadan, J. Viik, S. G. Aggarwal, R. Lehtinen, L. Ellis, et al.
Post-exercise assessment of cardiac repolarization alternans in patients with coronary artery disease using the modified moving average method.
J. Am. Coll. Cardiol.,
March 31, 2009;
53(13):
1130 - 1137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. V. Huikuri, M.J. P. Raatikainen, R. Moerch-Joergensen, J. Hartikainen, V. Virtanen, J. Boland, O. Anttonen, N. Hoest, L. V.A. Boersma, E. S. Platou, et al.
Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction
Eur. Heart J.,
March 2, 2009;
30(6):
689 - 698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bauer, P. Barthel, R. Schneider, K. Ulm, A. Muller, A. Joeinig, R. Stich, A. Kiviniemi, K. Hnatkova, H. Huikuri, et al.
Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk)
Eur. Heart J.,
March 1, 2009;
30(5):
576 - 583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Rosenbaum
T-Wave Alternans in the Sudden Cardiac Death in Heart Failure Trial Population: Signal or Noise?
Circulation,
November 11, 2008;
118(20):
2015 - 2018.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bauer, M. Malik, G. Schmidt, P. Barthel, H. Bonnemeier, I. Cygankiewicz, P. Guzik, F. Lombardi, A. Muller, A. Oto, et al.
Heart Rate Turbulence: Standards of Measurement, Physiological Interpretation, and Clinical Use: International Society for Holter and Noninvasive Electrophysiology Consensus
J. Am. Coll. Cardiol.,
October 21, 2008;
52(17):
1353 - 1365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Goyal and S. R. Punnam
Noninvasive Risk Assessment Early After a Myocardial Infarction: Are We Looking at the Right Indicators?
J. Am. Coll. Cardiol.,
May 13, 2008;
51(19):
1910 - 1910.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. V. Exner and on behalf of the REFINE Investigators
Reply
J. Am. Coll. Cardiol.,
May 13, 2008;
51(19):
1910 - 1911.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the year in JACC 2007.
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
490 - 512.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G.F. Cleland, A. P. Coletta, A. T. Abdellah, D. Cullington, A. L. Clark, and A. S. Rigby
Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy
Eur J Heart Fail,
January 1, 2008;
10(1):
102 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sleight
New Methods for Risk Stratification in Patients After Myocardial Infarction: Autonomic Control and Substrate Sensitivity
J. Am. Coll. Cardiol.,
December 11, 2007;
50(24):
2291 - 2293.
[Full Text]
[PDF]
|
 |
|
|